Literature DB >> 7039429

A cooling system for prostaglandin infusions.

M M Krausz, R E Justice, T Utsunomiya, H B Hechtman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7039429     DOI： 10.1007/bf02363459

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN： 0090-6964            Impact factor:   3.934


× No keyword cloud information.
  7 in total

1.  Chemical stability of prostacyclin (PGI2) in aqueous solutions.

Authors:  M J Cho; M A Allen
Journal:  Prostaglandins       Date:  1978-06

2.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

3.  A method for administration of prolonged intravenous infusion of prostacyclin (PGI2) to unanesthetized rats.

Authors:  J R Weeks
Journal:  Prostaglandins       Date:  1979-04

4.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03

5.  Disappearance of prostacyclin (PGI2) in the circulation of the dog [proceedings].

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

6.  Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-01

7.  Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.

Authors:  S Moncada; E A Higgs; J R Vane
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.